Circulating sphingolipids and relationship to cardiac remodelling before and following a low-energy diet in asymptomatic Type 2 Diabetes
Abstract Background Heart failure with preserved ejection fraction (HFpEF) is a heterogenous multi-system syndrome with limited efficacious treatment options. The prevalence of Type 2 diabetes (T2D) continues to rise and predisposes patients to HFpEF, and HFpEF remains one of the biggest challenges...
Main Authors: | Emer M. Brady, Thong H. Cao, Alastair J. Moss, Lavanya Athithan, Sarah L. Ayton, Emma Redman, Stavroula Argyridou, Matthew P. M. Graham-Brown, Colleen B. Maxwell, Donald J. L. Jones, Leong Ng, Thomas Yates, Melanie J Davies, Gerry P. McCann, Gaurav S. Gulsin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12872-023-03623-y |
Similar Items
-
Sphingolipids in neurodegenerative diseases
by: Xueyang Pan, et al.
Published: (2023-02-01) -
Editorial: Bioactive sphingolipids in health and disease
by: Mutay Aslan, et al.
Published: (2022-10-01) -
A Review of the Role of Sphingolipids in Apoptosis Phenomenon
by: M Mashhadi Akbar Boojar, et al.
Published: (2018-12-01) -
Neurodegenerative Disorders: Spotlight on Sphingolipids
by: Frida Mandik, et al.
Published: (2021-11-01) -
Editorial: Sphingolipid metabolism and cancer
by: Margarita M. Ivanova, et al.
Published: (2022-11-01)